89125-96-2 Usage
Uses
Used in Pharmaceutical Industry:
6-Iod-4-methylmercapto-pyrimidin is used as a building block for the synthesis of various pharmaceuticals and drug candidates. Its unique structure with iodine and sulfur atoms allows for the development of new and innovative medications.
Used in Organic Synthesis:
6-Iod-4-methylmercapto-pyrimidin is used as a reagent in organic synthesis, enabling the creation of a wide range of chemical compounds for various applications.
Used in Chemical Reactions:
6-Iod-4-methylmercapto-pyrimidin is utilized as a reagent in chemical reactions, facilitating the synthesis of new compounds and aiding in the advancement of chemical research.
Used in Medicine and Biotechnology:
The derivatives of 6-Iod-4-methylmercapto-pyrimidin have shown potential biological activity, making them valuable for investigation in medicine and biotechnology. Their potential applications in these fields are currently being explored, with the aim of developing new treatments and therapies.
Check Digit Verification of cas no
The CAS Registry Mumber 89125-96-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,9,1,2 and 5 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 89125-96:
(7*8)+(6*9)+(5*1)+(4*2)+(3*5)+(2*9)+(1*6)=162
162 % 10 = 2
So 89125-96-2 is a valid CAS Registry Number.
89125-96-2Relevant academic research and scientific papers
COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS
-
Page/Page column 27, (2011/09/14)
The invention provides a novel class of compounds of Formula (I) (wherein A, Y, R2, R3, R4 and R5 are defined in the summary of the invention), pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of B-Raf.
[4,5']BIPYRIMIDINYL-6,4'-DIAMINE DERIVATIVES AS PROTEIN KINASE INHBITORS
-
Page/Page column 26, 60-61, (2008/06/13)
The invention provides a novel class of compounds of the Formula (I): in which the symbols have the meanings given in the description and claims, to pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prev
